Patent · US Active

Method of treating cancer

US8940299B2 · kind B2 · utility

10Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 2, 2009
Grant dateJan 27, 2015
Priority date
Expiry dateJul 22, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for inducing apoptosis of a neoplastic cell expressing C3aR or C5aR includes administering at least one complement antagonist to the cell so that the at least one complement antagonist substantially reduces or inhibits the activity of protein kinase B in the neoplastic cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.